首页 | 本学科首页   官方微博 | 高级检索  
     检索      

C3d对减毒沙门氏菌介导的NDV DNA疫苗诱导的特异性体液免疫应答的增强作用
引用本文:潘志明,袁舟,刘蓓蓓,游猛,蔡雯婷,刘萌,焦新安.C3d对减毒沙门氏菌介导的NDV DNA疫苗诱导的特异性体液免疫应答的增强作用[J].农业生物技术学报,2009,17(5):745-749.
作者姓名:潘志明  袁舟  刘蓓蓓  游猛  蔡雯婷  刘萌  焦新安
作者单位:扬州大学江苏省人兽共患病学重点实验室,扬州,225009
基金项目:国家自然科学基金,高等学校科技创新工程重大项目培育资金,江苏省自然科学基金,江苏省高校自然科学基础研究项目,扬州大学大学生科技创新基金 
摘    要:采用PCR技术从重组质粒pVAX1-F扩增出新城疫病毒F48E8株的融合蛋白(F)基因,将其克隆入含有3 拷贝C3d 编码基因的pTR-C3d3质粒中,获得重组质粒pTR-F-C3d3。将F-C3d3基因片段从pTR-F-C3d3中切出,克隆入真核表达质粒pVAX1中,获得重组真核表达质粒pVAX1-F-C3d3。将pVAX1-F-C3d3转化减毒鼠伤寒沙门氏菌SL7207,构建成功携带DNA疫苗的重组沙门氏菌SL7207(pVAX1-F-C3d3)。重组菌分别以1×109 CFU的剂量两次口服免疫1日龄SPF鸡,结果显示,SL7207(pVAX1-F-C3d3)激发产生的血清抗体效价与SL7207 (pVAX1-F)免疫组之间存在显著性差异(P < 0.05)。SL7207(pVAX1-F-C3d3)免疫组的小肠黏膜抗体效价高于SL7207(pVAX1-F)免疫组,但两者间差异不显著(P > 0.05)。提示C3d可增强减毒沙门氏菌介导的NDV DNA疫苗诱导的特异性体液免疫应答水平,这为提高基于减毒沙门氏菌的NDV基因工程疫苗的免疫效果提供了新的途径。

关 键 词:C3d  减毒沙门氏菌  新城疫  DNA疫苗  体液免疫应答
收稿时间:2008-11-12
修稿时间:2009-1-12

Enhancement of the Humoral Immune Response against the Attenuated Salmonella typhimurium Harbouring Newcastle disease virus DNA Vaccine by C3d Molecule
PAN Zhi-ming,YUAN Zhou,LIU Bei-bei,YOU Meng,CAI Wen-ting,LIU Meng,JIAO Xin-an.Enhancement of the Humoral Immune Response against the Attenuated Salmonella typhimurium Harbouring Newcastle disease virus DNA Vaccine by C3d Molecule[J].Journal of Agricultural Biotechnology,2009,17(5):745-749.
Authors:PAN Zhi-ming  YUAN Zhou  LIU Bei-bei  YOU Meng  CAI Wen-ting  LIU Meng  JIAO Xin-an
Institution:PAN Zhi-ming,YUAN Zhou,LIU Bei-bei,YOU Meng,CAI Wen-ting,LIU Meng,JIAO Xin-an(Jiangsu Key Laboratory of Zoonosis,Yangzhou University,Yangzhou 225009,China)
Abstract:The fusion protein (F) gene of Newcastle disease virus was amplified by polymerase chain reaction (PCR) from the recombinant eukaryotic expression plasmid pVAX1-F, and subcloned into the plasmid pTR-C3d3 containing three copies of C3d. The F-C3d3 gene was identified by sequencing and cloned into eukaryotic expression vector pVAX1. The recombinant plasmid pVAX1-F-C3d3 was transformed into attenuated Salmonella typhimurium SL7207, and the recombinant was designated as SL7207(pVAX1-F-C3d3). One-day-old SPF chickens were immunized orally with SL7207(pVAX1-F-C3d3) at the dosage of 1×109 CFU and boosted two weeks later with the same dose. The serum antibodies responses specific to NDV were observed in chickens immunized with SL7207(pVAX1-F-C3d3) on day 14 and 28, and their levels were significantly higher than that of SL7207(pVAX1-F) (P < 0.05). Intestinal mucosal immune response were observed in chickens immunized with recombinant bacteria on day 28, and their levels were significantly higher than that of negative and positive control (P < 0.05), but there was not significance between the groups SL7207(pVAX1-F-C3d3) and SL7207(pVAX1-F). These results indicated that three copies C3d could enhance humoral immune response against NDV induced by attenuated Salmonella typhimurium harbouring DNA vaccine. A novel mucosal DNA vaccine was developed and could be useful for controlling the infection and epidemic of Newcastle disease in the poultry.
Keywords:C3d
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《农业生物技术学报》浏览原始摘要信息
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号